Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nissha Sonneboard Pharmaceutical is a Japanese pharmaceutical company that specializes in the manufacturing and sale of ethical and over-the-counter drugs. Originally founded in 1941 as Sonneboard Pharmaceutical, the company became a subsidiary of Nissha Co., Ltd. in 2016. The firm operates as a Contract Development and Manufacturing Organization (CDMO), offering expertise in the production of external preparations like ointments and creams, as well as oral solid dosages. Their manufacturing facility in Hachioji is compliant with Good Manufacturing Practice (GMP) standards, ensuring high-quality production for both domestic and international markets. In addition to contract services, they maintain a portfolio of proprietary products under the Zonne brand and various generic medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NISSHAゾンネボード製薬.